Timothy T. Richards sold $133k of CLPT
director at ClearPoint Neuro, Inc.. 10,000 shares at an average of $13.28, traded Jun 10, 2025, filed Jun 12, 2025.
Score components
- +15RoleDirector
- +11Trade size$133k at market
- +5Share of holdings soldSold 11% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-085714, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 10, 2025 | SOpen-market sale Common Stock | -10,000 | $13.28 | $133k | 77,381 | Jun 12, 2025 |
Related signals
Other insiders at ClearPoint Neuro, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 19Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $303k 19,951 shares | -9% | |
| 11Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $46k 2,943 shares | -1% | |
| 24Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $322k 20,000 shares | -63% | |
| 31Weak | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $714k 26,463 shares | -11% | |
| 54Moderate | ClearPoint Neuro, Inc. | Joseph Burnett CEO and President | $282k 21,247 shares | -8% | |
| 46Moderate | ClearPoint Neuro, Inc. | Lynnette C Fallon director | $128k 10,200 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.